Scleroderma Translational Research Partnership Award (DOD).

B Scope: b The Defense Department's U.S. Army Medical Research Acquisition Activity seeks applications for the Scleroderma Translational Research Partnership Award (TRPA) announcement to support partnerships between clinicians, research scientists, and other disciplines that will accelerate the movement of promising ideas in scleroderma into clinical applications. B Areas: b DOD said funding supports the development of translational research collaborations between two or more investigators to address a central problem or question in scleroderma in a manner that would be less readily achievable through separate efforts. [Extracted from the article]

Copyright of Federal Grants & Contracts is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)